Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
2019 · Signal Transduction and Targeted Therapy · 1,045 citations
https://doi.org/10.1038/s41392-019-0095-0
X
Xuelei Ma
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
416
Papers
15.7K
Citations
57
h-index
244
i10-index
Xuelei Ma is an academic researcher from Qingdao University. The author has contributed to research in topics: Radiomics and Machine Learning in Medical Imaging & Cancer Immunotherapy and Biomarkers & Cancer-related molecular mechanisms research. The author has an h-index of 57, co-authored 354 publications.
ORCID: 0000-0002-9148-5001Papers by this author
worksImmunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
2022 · Advanced Science · 610 citations
https://doi.org/10.1002/advs.202201734
Preparation and application of pH-responsive drug delivery systems
2022 · Journal of Controlled Release · 504 citations
https://doi.org/10.1016/j.jconrel.2022.05.056
Metabolic reprogramming in cancer: Mechanisms and therapeutics
2023 · MedComm · 209 citations
https://doi.org/10.1002/mco2.218
Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies
2021 · Signal Transduction and Targeted Therapy · 116 citations
https://doi.org/10.1038/s41392-021-00733-x
Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy
2022 · Molecular Biomedicine · 111 citations
https://doi.org/10.1186/s43556-022-00071-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat